Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debbie L Hay

Showing results (41-50 of 144) with videos related to

Pageof 15
Sort By:
Headache|August 7, 2025
Calcitonin gene-related peptide and headache: Comparison of two commonly used assay kits highlights the perils of measuring neuropeptides with enzyme-linked immunosorbent assaysMichael L Garelja, Tayla A Rees, Debbie L Hay
Biophysical Journal|April 25, 2006
Characterization of the structure of RAMP1 by mutagenesis and molecular modelingJohn Simms, Debbie L Hay, Mark Wheatley, et al.
Pharmacology Research & Perspectives|June 13, 2020
Agonist bias and agonist-dependent antagonism at corticotrophin releasing factor receptorsZoe Tasma, Peter Wills, Debbie L Hay, et al.
Molecular Pharmacology|September 9, 2006
Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4-(4-pyridinyl)-l-piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl) (BIBN4096BS) affinity for calcitonin gene-related peptide and amylin receptors--the role of receptor activity modifying protein 1Debbie L Hay, George Christopoulos, Arthur Christopoulos, et al.
Trends in Pharmacological Sciences|April 26, 2022
Atogepant (Qulipta®) for migraine preventionDebbie L Hay, Christopher S Walker, Paul W R Harris
British Journal of Pharmacology|June 11, 2011
The pharmacology of adrenomedullin 2/intermedinYanguo Hong, Debbie L Hay, Remi Quirion, et al.
Frontiers in Pharmacology|September 25, 2020
Antagonism of CGRP Signaling by Rimegepant at Two ReceptorsKylie S Pan, Andrew Siow, Debbie L Hay, et al.
Peptides|March 30, 2010
A key role for tryptophan 84 in receptor activity-modifying protein 1 in the amylin 1 receptorJoseph J Gingell, Tao Qi, Richard J Bailey, et al.
Cephalalgia : an International Journal of Headache|March 24, 2018
Molecular studies of CGRP and the CGRP family of peptides in the central nervous systemErica R Hendrikse, Rebekah L Bower, Debbie L Hay, et al.
British Journal of Pharmacology|October 24, 2017
Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25Debbie L Hay, Michael L Garelja, David R Poyner, et al.
Pageof 15

Showing results (41-50 of 144) with videos related to

Sort By:
Pageof 15
Headache|August 7, 2025
Calcitonin gene-related peptide and headache: Comparison of two commonly used assay kits highlights the perils of measuring neuropeptides with enzyme-linked immunosorbent assaysMichael L Garelja, Tayla A Rees, Debbie L Hay
Biophysical Journal|April 25, 2006
Characterization of the structure of RAMP1 by mutagenesis and molecular modelingJohn Simms, Debbie L Hay, Mark Wheatley, et al.
Pharmacology Research & Perspectives|June 13, 2020
Agonist bias and agonist-dependent antagonism at corticotrophin releasing factor receptorsZoe Tasma, Peter Wills, Debbie L Hay, et al.
Molecular Pharmacology|September 9, 2006
Determinants of 1-piperidinecarboxamide, N-[2-[[5-amino-l-[[4-(4-pyridinyl)-l-piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl) (BIBN4096BS) affinity for calcitonin gene-related peptide and amylin receptors--the role of receptor activity modifying protein 1Debbie L Hay, George Christopoulos, Arthur Christopoulos, et al.
Trends in Pharmacological Sciences|April 26, 2022
Atogepant (Qulipta®) for migraine preventionDebbie L Hay, Christopher S Walker, Paul W R Harris
British Journal of Pharmacology|June 11, 2011
The pharmacology of adrenomedullin 2/intermedinYanguo Hong, Debbie L Hay, Remi Quirion, et al.
Frontiers in Pharmacology|September 25, 2020
Antagonism of CGRP Signaling by Rimegepant at Two ReceptorsKylie S Pan, Andrew Siow, Debbie L Hay, et al.
Peptides|March 30, 2010
A key role for tryptophan 84 in receptor activity-modifying protein 1 in the amylin 1 receptorJoseph J Gingell, Tao Qi, Richard J Bailey, et al.
Cephalalgia : an International Journal of Headache|March 24, 2018
Molecular studies of CGRP and the CGRP family of peptides in the central nervous systemErica R Hendrikse, Rebekah L Bower, Debbie L Hay, et al.
British Journal of Pharmacology|October 24, 2017
Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25Debbie L Hay, Michael L Garelja, David R Poyner, et al.
Pageof 15